PHARMACARE COSTING IN CANADA Estimated Costs of Proposed National Pharmacare Programs.
Full report available here.
Events
29
Feb2016
26
Feb2016
Revised Procedures for CDR and pCODR
For all drug applications filed for review through either the Common Drug Review (CDR) or ... Read More
23
Feb2016
pCPA February Update – Federal Drug Plans officially join the pCPA and the full Office team is now in place
/ Canada, News, pCPA, What's New
In a recent update released to their website, the pan-Canadian Pharmaceutical Alliance (pCPA) announced 2 significant developments:
The Federal Drug ... Read More
17
Feb2016
Ontario has released the February 2016 Summary of Changes document, which includes the addition of Hospira’s Inflectra at a price ... Read More
17
Feb2016
Suzanne McGurn, the Executive Officer of the Ontario Public Drug Programs, issued a statement on behalf of the Pan Canadian ... Read More
12
Feb2016
The Alberta Price Confirmation (APC) is issued prior to an Alberta Drug Benefit List (ADBL) publication. The APC is a ... Read More
12
Feb2016
As part of the National Prescription Drug Utilization Information System (NPDUIS), the Patented Medicine Prices Review Board (PMPRB) has recently ... Read More
12
Feb2016
Modifications to the Procedure for Filing a Drug Submission Application for Generic Drugs with INESSS
/ INESSS, pCPA, Quebec, What's New
Since Québec is now participating in the pan-Canadian Pharmaceutical Alliance (pCPA), INESSS recently communicated that information sharing has now become ... Read More